Sinovac Reports Unaudited Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil falls as Trump comments on Iran talks ease supply fears
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Powerful quake hits Panama, damages homes; canal operations normal
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Sinovac Biotech (SVA) Tops Q2 EPS by 5c
August 12, 2015 4:32 PM EDTSinovac Biotech (NASDAQ: SVA) reported Q2 EPS of $0.04, $0.05 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $15.7 million.
For earnings history and earnings-related data on Sinovac Biotech (SVA) click here.
... More


